Centro Italiano Macula, Rome, Italy.
"Careggi" Hospital, Florence, Italy.
Curr Pharm Des. 2018;24(41):4843-4852. doi: 10.2174/1381612825666190130125136.
Pharmacological adjuncts to vitrectomy surgery are useful tools to better deal with surgery. Their introduction has enriched the therapeutic choice before, during and after operations. Although several classifications could be made to frame adjuncts to vitrectomy, we preferred to divide the pharmacological adjuncts to vitrectomy surgery for therapeutic use in the pre-operatory procedure (neo-adjuvant), for intraoperative use and for post-operatory practice (adjuvant). This type of classification allowed us to explore all the adjuncts based on the timing of their use. The actual interest in vitrectomy surgery is giving rise to considerable interest in new molecules with and without the pharmacological effect that will soon be available for the aid of vitreoretinal surgery.
玻璃体切割手术的药物辅助是更好地进行手术的有用工具。它们的引入丰富了手术前、手术中和手术后的治疗选择。尽管可以进行几种分类来框定玻璃体切割手术的辅助手段，但我们更愿意将玻璃体切割手术的药物辅助手段分为术前（新辅助）、术中及术后（辅助）使用。这种分类方法使我们能够根据其使用时间来探索所有的辅助手段。玻璃体切割手术的实际应用引起了人们对新分子的极大兴趣，这些新分子具有或不具有药理作用，很快将可用于辅助玻璃体视网膜手术。
